M&A Deal Summary |
|
|---|---|
| Date | 2019-05-08 |
| Target | EuroParcs |
| Sector | Leisure |
| Buyer(s) | Waterland Private Equity |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 14.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Waterland Private Equity Investments BV is a private equity firm focused on mid-sized company investments in Central Europe. Waterland looks for businesses with €10 to €200 million in revenue and generally seeks companies operating in fragmented markets or industries undergoing change as a result of: outsourcing, the aging population, and a growing population with increased purchasing power. The Firm typically partners with entrepreneurs and management teams to accelerate the growth of their businesses or complete buyouts and consolidation strategies. Waterland Private Equity Investments was formed in 1999 and is based in Bussum, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 75 of 121 |
| Sector: Leisure M&A | 5 of 5 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 30 of 45 |
| Country: Netherlands M&A | 29 of 38 |
| Year: 2019 M&A | 2 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-05 |
Infra Group
Temse, Belgium Infra Group provides design, installation, improvement, and maintenance of distribution networks; and offers full turnkey solutions and services to telecommunications, electricity, gas, heating and water operators and local authorities in Belgium. Infra Group was founded in 1966 and is based in Temse, Belgium. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-11 |
VivaNeo Deutschland
Frankfurt, Germany VivaNeo Deutschland GmbH is a European provider of fertility services, present in Germany, Austria, the Netherlands, and Denmark. VivaNeo GmbH comprises 9 IVF clinics across four countries, an egg donor bank, as well as a blood diagnostic laboratory and a dialysis center in Germany. VivaNeo GmbH holds the number 1 or 2 market position in market share terms in each of its markets. The group focus is on best-in-class patient experience and success rates. |
Sell | - |